Open-Angle Glaucoma (OAG) Global Market Report 2025

Description

Open-angle glaucoma (OAG) is a chronic and progressive eye condition in which the drainage canals in the eye gradually become blocked, causing an increase in intraocular pressure that damages the optic nerve. This damage typically occurs without noticeable symptoms until significant vision loss has occurred. Treatment focuses on lowering intraocular pressure to prevent further optic nerve damage and preserve vision through medications, laser therapies, or surgical procedures.

The main types of open-angle glaucoma (OAG) include open-angle glaucoma, angle-closure glaucoma, and other variants. Open-angle glaucoma is characterized by increased intraocular pressure, which leads to slow optic nerve damage and potential vision loss, often without early warning signs. The medications used to treat this condition include prostaglandin analogs, beta blockers, adrenergic agonists, carbonic anhydrase inhibitors, and others. The primary end users of these treatments include hospitals, homecare settings, specialty clinics, and more. These treatments are distributed through various channels such as hospital pharmacies, online pharmacies, and retail pharmacies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The open-angle glaucoma (OAG) market research report is one of a series of new reports from The Business Research Company that provides open-angle glaucoma (OAG) market statistics, including open-angle glaucoma (OAG) industry global market size, regional shares, competitors with open-angle glaucoma (OAG) market share, detailed open-angle glaucoma (OAG) market segments, market trends and opportunities, and any further data you may need to thrive in the open-angle glaucoma (OAG) industry. This open-angle glaucoma (OAG) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The open-angle glaucoma (oag) market size has grown strongly in recent years. It will grow from $6.13 billion in 2024 to $6.53 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to the increasing prevalence of glaucoma among aging populations, growing awareness about early detection of eye diseases, rising healthcare expenditure, government initiatives for vision care programs, and expansion of ophthalmology practices globally.

The open-angle glaucoma (oag) market size is expected to see strong growth in the next few years. It will grow to $8.36 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing demand for combination therapies, rising focus on personalized medicine, improved reimbursement policies for glaucoma treatments, increasing prevalence of lifestyle-induced ocular conditions, and rising demand for non-invasive diagnostic methods. Major trends in the forecast period include growing adoption of AI in glaucoma diagnostics, a shift toward outpatient glaucoma surgical procedures, increasing use of sustained-release glaucoma implants, rising integration of wearable technology for monitoring intraocular pressure, and heightened focus on sustainability in medical device manufacturing.

The forecast of 6.4% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of trabeculectomy devices and minimally invasive glaucoma surgery (MIGS) implants sourced from Germany and Israel, thereby delaying surgical interventions for progressive vision loss and elevating ophthalmology surgical expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing awareness of eye diseases is expected to drive the growth of the open-angle glaucoma (OAG) market in the future. Eye illnesses refer to conditions that affect the eyes' structure, function, or vision, ranging from minor issues such as dry eye to more severe conditions such as glaucoma and macular degeneration. The rising prevalence of these conditions is influenced by factors such as aging populations, extended screen time, higher rates of diabetes, environmental pollution, and lifestyle choices that negatively affect eye health. Open-angle glaucoma (OAG), which is a leading cause of blindness, particularly in older adults, highlights the importance of regular eye exams, early detection, and timely treatment to prevent irreversible vision loss. For example, in October 2023, the Royal National Institute of Blind People (RNIB), a UK-based charity for sight loss, reported that eye care outpatient appointments in the UK surpassed eight million in 2021/22, making it the most requested medical specialty. Furthermore, the number of people experiencing sight loss, which currently exceeds two million, is expected to double to over four million by 2050. As a result, the rising awareness of eye illnesses is fueling the growth of the open-angle glaucoma (OAG) market.

Leading companies in the open-angle glaucoma (OAG) market are focusing on the development of innovative solutions, such as minimally invasive glaucoma devices (MIGDs), to offer advanced, less invasive options for managing primary open-angle glaucoma while reducing dependence on traditional treatments. A minimally invasive glaucoma device (MIGD) includes various surgical implants and techniques aimed at lowering intraocular pressure in glaucoma patients through small incisions and minimal disturbance to ocular tissues. For example, in December 2023, iSTAR Medical, a medtech company based in Belgium, introduced MINIject in the Netherlands. This bio-integrating treatment for primary open-angle glaucoma uses a unique porous STAR material to improve fluid outflow and lower intraocular pressure. By reducing the need for traditional therapies, MINIject marks a significant advancement in glaucoma treatment, providing a safer and more effective management option for this major cause of irreversible blindness.

In July 2024, Alcon Inc., an ophthalmology company based in Switzerland, acquired BELKIN Vision Ltd. for $81 million. This acquisition is intended to strengthen Alcon's glaucoma portfolio by incorporating the direct selective laser trabeculoplasty (DSLT) device, an advanced first-line laser treatment for managing open-angle glaucoma. The acquisition supports Alcon's strategy to expand global access to innovative and minimally invasive glaucoma treatments. BELKIN Vision Ltd., based in Israel, is a medical device company that specializes in providing devices for the treatment of open-angle glaucoma.

Major players in the open-angle glaucoma (OAG) market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc, Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd., Boston Scientific, Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Mallinckrodt Pharmaceuticals, Thea Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Peregrine Eye Laser and Institute, and Inotek Pharmaceuticals.

North America was the largest region in the open-angle glaucoma (OAG) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in open-angle glaucoma (OAG) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the open-angle glaucoma (OAG) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The open-angle glaucoma (OAG) market consists of revenues earned by entities by providing services such as optometric services, surgical interventions, medication management, and patient education and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The open-angle glaucoma (OAG) market also includes sales of tonometers, visual field analyzers, and lubricating eye drops. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Open-Angle Glaucoma (OAG) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on open-angle glaucoma (oag) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for open-angle glaucoma (oag) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The open-angle glaucoma (oag) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Disease Type: Open Angle Glaucoma; Angle Closure Glaucoma; Other Disease Type
2) By Drug Class: Prostaglandin Analog; Beta Blockers; Adrenergic Agonist; Carbonic Anhydrase Inhibitors; Others Drug Class
3) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
Subsegments:
1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG); Secondary Open-Angle Glaucoma
2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma; Chronic Angle-Closure Glaucoma
3) By Other Disease Type: Normal-Tension Glaucoma; Congenital Glaucoma; Secondary Glaucoma
Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc; Novartis AG; Amgen Inc.; Teva Pharmaceutical Industries Ltd.; Boston Scientific; Alcon Inc.; Bausch Health Companies Inc.; Hoya Corporation; Sun Pharmaceutical Industries Ltd.; Santen Pharmaceuticals; Mallinckrodt Pharmaceuticals; Thea Pharma; Glaukos Corporation; Quantel Medical; EyePoint Pharmaceuticals Inc.; iSTAR Medical; Nicox Ophthalmics; Visus Therapeutics; Peregrine Eye Laser and Institute; Inotek Pharmaceuticals
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r33841u

1. Executive Summary

2. Open-Angle Glaucoma (OAG) Market Characteristics

3. Open-Angle Glaucoma (OAG) Market Trends And Strategies

4. Open-Angle Glaucoma (OAG) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Open-Angle Glaucoma (OAG) Growth Analysis And Strategic Analysis Framework

5.1. Global Open-Angle Glaucoma (OAG) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Open-Angle Glaucoma (OAG) Market Growth Rate Analysis
5.4. Global Open-Angle Glaucoma (OAG) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Open-Angle Glaucoma (OAG) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Open-Angle Glaucoma (OAG) Total Addressable Market (TAM)

6. Open-Angle Glaucoma (OAG) Market Segmentation

6.1. Global Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Open Angle Glaucoma
Angle Closure Glaucoma
Other Disease Type
6.2. Global Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prostaglandin Analog
Beta Blockers
Adrenergic Agonist
Carbonic Anhydrase Inhibitors
Others Drug Class
6.3. Global Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homecare
Specialty Clinics
Other End Users
6.4. Global Open-Angle Glaucoma (OAG) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
6.5. Global Open-Angle Glaucoma (OAG) Market, Sub-Segmentation Of Open Angle Glaucoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Primary Open-Angle Glaucoma (POAG)
Secondary Open-Angle Glaucoma
6.6. Global Open-Angle Glaucoma (OAG) Market, Sub-Segmentation Of Angle Closure Glaucoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Acute Angle-Closure Glaucoma
Chronic Angle-Closure Glaucoma
6.7. Global Open-Angle Glaucoma (OAG) Market, Sub-Segmentation Of Other Disease Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Normal-Tension Glaucoma
Congenital Glaucoma
Secondary Glaucoma

7. Open-Angle Glaucoma (OAG) Market Regional And Country Analysis

7.1. Global Open-Angle Glaucoma (OAG) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Open-Angle Glaucoma (OAG) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Open-Angle Glaucoma (OAG) Market

8.1. Asia-Pacific Open-Angle Glaucoma (OAG) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Open-Angle Glaucoma (OAG) Market

9.1. China Open-Angle Glaucoma (OAG) Market Overview
9.2. China Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Open-Angle Glaucoma (OAG) Market

10.1. India Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Open-Angle Glaucoma (OAG) Market

11.1. Japan Open-Angle Glaucoma (OAG) Market Overview
11.2. Japan Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Open-Angle Glaucoma (OAG) Market

12.1. Australia Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Open-Angle Glaucoma (OAG) Market

13.1. Indonesia Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Open-Angle Glaucoma (OAG) Market

14.1. South Korea Open-Angle Glaucoma (OAG) Market Overview
14.2. South Korea Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Open-Angle Glaucoma (OAG) Market

15.1. Western Europe Open-Angle Glaucoma (OAG) Market Overview
15.2. Western Europe Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Open-Angle Glaucoma (OAG) Market

16.1. UK Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Open-Angle Glaucoma (OAG) Market

17.1. Germany Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Open-Angle Glaucoma (OAG) Market

18.1. France Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Open-Angle Glaucoma (OAG) Market

19.1. Italy Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Open-Angle Glaucoma (OAG) Market

20.1. Spain Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Open-Angle Glaucoma (OAG) Market

21.1. Eastern Europe Open-Angle Glaucoma (OAG) Market Overview
21.2. Eastern Europe Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Open-Angle Glaucoma (OAG) Market

22.1. Russia Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Open-Angle Glaucoma (OAG) Market

23.1. North America Open-Angle Glaucoma (OAG) Market Overview
23.2. North America Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Open-Angle Glaucoma (OAG) Market

24.1. USA Open-Angle Glaucoma (OAG) Market Overview
24.2. USA Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Open-Angle Glaucoma (OAG) Market

25.1. Canada Open-Angle Glaucoma (OAG) Market Overview
25.2. Canada Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Open-Angle Glaucoma (OAG) Market

26.1. South America Open-Angle Glaucoma (OAG) Market Overview
26.2. South America Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Open-Angle Glaucoma (OAG) Market

27.1. Brazil Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Open-Angle Glaucoma (OAG) Market

28.1. Middle East Open-Angle Glaucoma (OAG) Market Overview
28.2. Middle East Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Open-Angle Glaucoma (OAG) Market

29.1. Africa Open-Angle Glaucoma (OAG) Market Overview
29.2. Africa Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Open-Angle Glaucoma (OAG) Market Competitive Landscape And Company Profiles

30.1. Open-Angle Glaucoma (OAG) Market Competitive Landscape
30.2. Open-Angle Glaucoma (OAG) Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Open-Angle Glaucoma (OAG) Market Other Major And Innovative Companies

31.1. Teva Pharmaceutical Industries Ltd.
31.2. Boston Scientific
31.3. Alcon Inc.
31.4. Bausch Health Companies Inc.
31.5. Hoya Corporation
31.6. Sun Pharmaceutical Industries Ltd.
31.7. Santen Pharmaceuticals
31.8. Mallinckrodt Pharmaceuticals
31.9. Thea Pharma
31.10. Glaukos Corporation
31.11. Quantel Medical
31.12. EyePoint Pharmaceuticals Inc.
31.13. iSTAR Medical
31.14. Nicox Ophthalmics
31.15. Visus Therapeutics

32. Global Open-Angle Glaucoma (OAG) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Open-Angle Glaucoma (OAG) Market

34. Recent Developments In The Open-Angle Glaucoma (OAG) Market

35. Open-Angle Glaucoma (OAG) Market High Potential Countries, Segments and Strategies

35.1 Open-Angle Glaucoma (OAG) Market In 2029 - Countries Offering Most New Opportunities
35.2 Open-Angle Glaucoma (OAG) Market In 2029 - Segments Offering Most New Opportunities
35.3 Open-Angle Glaucoma (OAG) Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer